Cipla Limited has announced the appointment of Mr. Sushrut Kulkarni as the new President & Global Chief of Integrated Product Development, effective 18th May 2026. Additionally, the company confirmed that its 90th Annual General Meeting will be held on 25th June 2026. The board also approved the appointment of M/s Joshi Apte & Associates as Cost Auditors for the 2026-27 financial year and finalized new grants for employee stock options and appreciation rights.
Leadership Appointment
Cipla has bolstered its leadership team with the appointment of Mr. Sushrut Kulkarni as the new President & Global Chief for Integrated Product Development (IPD). He will also serve as a member of the Management Council. With a career spanning three decades, Mr. Kulkarni brings extensive expertise in managing complex R&D operations and product pipelines, having previously held senior roles at Dr. Reddy’s Laboratories, Glenmark, and Zydus Lifesciences.
Corporate Governance and Planning
The company has scheduled its 90th Annual General Meeting for Thursday, 25th June 2026. As part of its fiscal governance, the board has appointed M/s Joshi Apte & Associates as Cost Auditors for the 2026-27 fiscal year, ensuring continued diligence in cost management and regulatory compliance.
Employee Incentive Programs
The company has approved new grants under its existing employee benefit schemes to foster talent retention. This includes the issuance of stock options under the ESOS 2013-A scheme and Employee Stock Appreciation Rights (ESARs) under the ESAR 2021 scheme. These grants are subject to defined vesting periods ranging from one to three years, with an exercise price of INR 2 per option or share.
Source: BSE
